SecBot SecBot
6-K ·Filed May 18, 2026

BRSYF

Brainsway Ltd.
NEUTRAL
Impact 4/10
Horizonweeks Processed6mo ago SEC0001171843-26-003501
Notable filing: 6-K
Actionable Insight • Neutral

This is a routine strategic investment with no immediate earnings impact. Monitor for future milestone payments and any revenue contribution from Hopemark, but the near-term stock catalyst is minimal. The prior 20-F showed strong fundamentals, and this deal does not alter that trajectory.

DirectionNeutral
Confidencehigh
Horizonweeks

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$16.84
T+0 close · May 18, 2026 · via day close
Latest settled
−10.15%
T+60 · $15.13
Vs SPY
−15.01%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · May 18 $16.84entry
  2. T+1 · 6mo ago 0.00%α +0.65% · $16.84
  3. T+5 · 6mo ago 0.00%α −1.62% · $16.84
  4. T+20 · 5mo ago 0.00%α −1.58% · $16.84
  5. T+60 · 3mo ago −10.15%α −15.01% · $15.13

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

BrainsWay announced a minority-stake investment of $1.5 million (with potential for an additional $1.5 million via milestones) in Hopemark Health, a mental health provider in Illinois. This is a continuation of BrainsWay's strategy to partner with clinical platforms to expand access to its Deep TMS technology. The investment is small relative to BrainsWay's $52.2 million annual revenue and is not expected to materially impact near-term financials.

Key Facts

  • BrainsWay will invest $1.5 million initially, with potential for an additional $1.5 million via milestone-based investments, for a minority position in Hopemark Health.
  • The investment is in the form of a preferred, annually compounding security with a redemption mechanism.
  • This is part of a series of similar minority-stake investments by BrainsWay in North American mental health providers.
  • BrainsWay reported 2025 revenue of $52.2 million and net income of $7.6 million in its recent 20-F filing.
  • The transaction is small-scale (up to $3 million total) and does not change BrainsWay's core business or financial outlook.

Financial Impact

Up to $3 million total investment, representing approximately 5.7% of BrainsWay's 2025 annual revenue of $52.2 million. The initial $1.5 million is about 2.9% of revenue.

cashinvestment securities

Risk Factors

  • Investment may not produce profitable returns, as noted in the forward-looking statement risk factors.
  • Milestone-based additional investment may not materialize if Hopemark underperforms.
  • Minority stake provides limited control over Hopemark's operations.

Market Snapshot

Exchange
OTC
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
86% bullish (7 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001171843-26-003501
Document: f6k_051726.htm0001171843-26-003501
Document: 0001171843-26-003501-index-headers.html0001171843-26-003501
Document: 0001171843-26-003501-index.html0001171843-26-003501
Document: 0001171843-26-003501.txt0001171843-26-003501

Track record

5 reports on BRSYF

Performance horizon

2 of 4 bullish or bearish reports moved the stock their way by T+60. Best: +24.28% at T+20 after the Apr 15, 2026 report. 2 of 4 went positive at some point.

Filters
  1. Jun 9, 202622w ago 6-K Bullish 7/10 Entry $16.84 to $15.13 Now $10.62 −36.94% ▼ −10.15% −14.24% vs SPY
  2. May 18, 202626w ago 6-K Neutral 4/10 Viewing Entry $16.84 to $15.13 Now $10.62 −36.94% ▼ −10.15% −15.01% vs SPY
  3. May 13, 202626w ago 6-K Bullish 8/10 Entry $16.84 to $15.13 Now $10.62 −36.94% ▼ −10.15% −14.59% vs SPY
  4. Apr 20, 202630w ago 20-F Bullish 7/10 Entry $13.55 to $15.13 Now $10.62 −21.62% ▲ +11.66% +4.76% vs SPY
  5. Apr 15, 202630w ago 6-K Bullish 7/10 Entry $13.55 to $15.13 Now $10.62 −21.62% ▲ +11.66% +3.52% vs SPY
Showing 5 of 5

US Market Status

Market Closed · Opens Wed (11h)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 18, 2026